Abstract: An example embodiment of the present invention provides a method of assessing the condition of a pavement site, comprising: (a) acquiring aerial images of the site from above, for example by an unmanned aerial system (UAS); (b) using photogrammetry tools to generate an orthomosaic that represents the airport pavement surface; (c) using image analysis tools and machine learning methods to determine the location and extent of defects in the pavement; (c) producing an image representation of the site and the defects, where the location and extent of defects are discernible from the image; (d) using software application techniques to store and present defect data and other related information for client-side user access.

Abstract: An example embodiment of the present invention provides a method of assessing the condition of a pavement site, comprising: (a) acquiring aerial images of the site from above, for example by an unmanned aerial system (UAS); (b) using photogrammetry tools to generate an orthomosaic that represents the airport pavement surface; (c) using image analysis tools and machine learning methods to determine the location and extent of defects in the pavement; (c) producing an image representation of the site and the defects, where the location and extent of defects are discernible from the image; (d) using software application techniques to store and present defect data and other related information for client-side user access.

Abstract: Systems and methods for identifying an adverse effect of a pharmaceutical substance are provided. A system may tokenize an electronic medical record for a plurality of tokens. The system may further generate a distance score between a first vector of a word embedding model and a second vector of the word embedding model. The first vector may correspond to a substance token and the second vector may correspond to a condition token. The system may further detect an absence of a preventative association between the substance token and the condition token in a prevention repository. The system may further generate a causal link indication indicative of a causal link between the substance token and the condition token in response to the distance score being greater than a threshold value and detection of the absence of the preventative association between the substance token and the condition token.

Abstract: Systems and methods for identifying an adverse effect of a pharmaceutical substance are provided. A system may tokenize an electronic medical record for a plurality of tokens. The system may further generate a distance score between a first vector of a word embedding model and a second vector of the word embedding model. The first vector may correspond to a substance token and the second vector may correspond to a condition token. The system may further detect an absence of a preventative association between the substance token and the condition token in a prevention repository. The system may further generate a causal link indication indicative of a causal link between the substance token and the condition token in response to the distance score being greater than a threshold value and detection of the absence of the preventative association between the substance token and the condition token.